Progenics Pharmaceuticals Inc.

(PGNX)

By |

Profile

Progenics Pharmaceuticals Inc is engaged in the development of medicines for oncology. The Company develops products for the treatment of prostate cancer, opioid-induced constipation, or OIC, as well as OIC for non-cancer pain.

Contact Information

Website: www.progenics.com
Main Phone: +1 914 789-2800
Address: 777 Old Saw Mill River Road
State: NY
City / Town: Tarrytown
Country: USA
Postal Code: 10591

Issuer Information

Exchange: NGS
Employees: 66
NAICS: Pharmaceutical P
$ 8.64 ($ 0.03) (-0.35%)
Last Price 8.64 Change $ -0.03 Change % -0.35 Tick N/A
Bid 8.25 Bid Size 200.00 Ask 9.75 Ask Size 100.00
Open 8.63 High 8.82 Low 8.27 Prev Close 8.67
Last Trade Volume 1 mi 52 Wk Hi 9.23 52 Wk Low 3.61
Market Cap 605.2 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 70,051,441.00 EPS (TTM) 0.16 PE Ratio 55.90 Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
Mark R. Baker 1,000
Mark R. Baker 1,000
Mark R. Baker 1,000
Mark R. Baker 1,000
Mark R. Baker 1,000
Mark R. Baker 1,000
Mark R. Baker 1,000
Mark R. Baker 1,000
Mark R. Baker 1,000
Mark R. Baker 1,000
Last 10 Sell Shares
Robert J. Israel 1,000
Robert J. Israel 1,000
Robert J. Israel 1,000
Robert J. Israel 1,000
Robert J. Israel 1,000
Robert J. Israel 1,000
Robert J. Israel 1,000
Robert J. Israel 1,000
Robert J. Israel 1,000
Robert J. Israel 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 14 14 14 14
Low Target Price Estimate 9 9 9 9
Mean Target Price Estimate 11.5 11.5 11.5 11.5
Standard Deviation 3.54 3.54 3.54 3.54
Date of Most Recent Estimate 08/04/16 08/04/16 07/22/16 08/19/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1